Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma

This brief report assesses the efficacy of pembrolizumab, an inhibitor of programmed cell death 1 protein and its ligands, in a patient and in biopsy specimens of a series of patients with locally advanced cutaneous squamous cell carcinoma.

http://ift.tt/2mPeirh